On Wednesday, a Hawaii Senate committee approved a House bill that would establish an advisory council to examine possible regulations to allow access to federal “breakthrough treatments” such as MDMA and psilocybin.
Rep. Adrian Tam (D), introduced psychedelics legislation in the Senate Health and Human Services Committee with amendments. It was approved in a 5-0 vote.
Members heard testimony from experts and advocates, including one representative of the Department of Health. The reform was supported by all 20 organizations and individuals who submitted written testimony prior to the hearing.
The department may be supporting the bill partly because the legislation was amended to allow the state to create a psychedelics advisory board. This is in contrast to the original mandated language that said the panel would be created.
The proposal was deemed prudent by the health department, which also promised to help prepare Hawaii for future treatments and technologies that are based on behavioral health and have been granted Breakthrough Therapy Designations (FDA) from the federal Food and Drug Administration.
This measure was approved by the House earlier in the month. It has been renamed to “Temporary Breakthrough Technology Designation Advisory Council”.
The bill was further amended at Thursday’s committee meeting to be effective upon its enactment. It was previously given a “defective deadline” of June 30, 20030–a tactic used in Hawaii to indicate that a bill requires more work before it can be passed.
According to the Senate panel, the bill states that the legislature believes that state officials should be empowered to review relevant laws and regulations whenever a breakthrough therapy is designated to review any new treatment for mental health and substance abuse to prepare them for approval by the federal Food and Drug Administration.”
The original designation of the department as the chair of the council was for the department. However, the governor has changed that to the Office of Wellness and Resiliency.
Here’s HB1340 as amended:
A council of advisors would be established to examine federal and state regulations regarding certain psychedelics. They also will review scientific literature on their use for mental health treatment.
FDA breakthrough therapies would be evaluated by the council within three months after FDA has given that designation to the substance.
The OWR director, the state attorney general, the law enforcement director, legislative leadership, and a physician would be required to make up the members of the council. Other members could be appointed by the OWR director and top legislators.
The body would have to review the “requirements specifications and guidelines for a healthcare professional to prescribe and offer various treatments to patients who might benefit.”
The council must submit a report to the legislature within one year of its convening.
An version of the Senate companion passed the chamber earlier in this month, and was referred to a House Committee.
Marijuana Moment tracks more than 1000 cannabis, psychedelics, and drug policy bills in the state legislatures and Congress this yea. Patreon supporters who pledge at least $25 per month get access to our interactive maps and charts, as well as a hearing calendar, so they don’t miss any developments.
Get access to our marijuana bill tracker by becoming a Patreon supporter.
—
The House has rejected a bill from Hawaii to legalize marijuana. However, advocates are shifting their focus to 2024 and hope to pass the reform during the second half the two-year legislative session.
Sen. Joy San Buenaventura, D. , passed the Senate earlier in the month. There were high hopes that the legislation would make it to the House. A hearing was not scheduled prior to the deadline for bills that were referred to more than three committees. This means it will have to wait until next year in order to move forward.
Over several sessions, legislators have tried to legalize the Aloha State. However, the reform was passed in the Senate in 2021. However, after it failed to pass a House committee by the key deadline, it was unable to move forward.
Former Democratic governor Dave Ige was a difficult advocate. He said that he wasn’t willing to allow legalization because it would conflict with federal law. This is despite Hawaii’s medical marijuana system allowing people to grow and sale cannabis, in violation of broad federal prohibition.
Now that Gov. Actors are now feeling empowered by the swearing-in of Josh Green (D). In November, he said he would sign a bill to legalize marijuana for adults. He already has ideas on how tax revenue from cannabis sales could be used.
Photo by Dick Culbert.
Marijuana Moment: The post Hawaii Senators approve Bill To Create Psychedelics Advisory Council To Prepare For Federal Legalization was first published
